Syros Pharmaceuticals Inc (SYRS)
5.645
+0.04
(+0.62%)
USD |
NASDAQ |
May 21, 16:00
5.645
0.00 (0.00%)
After-Hours: 20:00
Syros Pharmaceuticals Cash from Investing (Quarterly): -24.64M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -24.64M |
| December 31, 2023 | 1.522M |
| September 30, 2023 | 28.64M |
| June 30, 2023 | 32.92M |
| March 31, 2023 | -25.75M |
| December 31, 2022 | 37.72M |
| September 30, 2022 | 6.192M |
| June 30, 2022 | 15.89M |
| March 31, 2022 | 7.383M |
| December 31, 2021 | -0.245M |
| September 30, 2021 | -17.30M |
| June 30, 2021 | -34.84M |
| March 31, 2021 | -0.262M |
| December 31, 2020 | -0.029M |
| September 30, 2020 | -0.522M |
| June 30, 2020 | 4.012M |
| March 31, 2020 | 43.20M |
| December 31, 2019 | 16.95M |
| September 30, 2019 | -57.14M |
| Date | Value |
|---|---|
| June 30, 2019 | 32.68M |
| March 31, 2019 | -4.229M |
| December 31, 2018 | 20.04M |
| September 30, 2018 | -60.53M |
| June 30, 2018 | 17.48M |
| March 31, 2018 | 12.36M |
| December 31, 2017 | -0.069M |
| September 30, 2017 | -27.82M |
| June 30, 2017 | 10.19M |
| March 31, 2017 | 2.103M |
| December 31, 2016 | -25.33M |
| September 30, 2016 | -0.181M |
| June 30, 2016 | -0.302M |
| March 31, 2016 | -1.525M |
| December 31, 2015 | -0.293M |
| September 30, 2015 | -0.712M |
| June 30, 2015 | -0.063M |
| March 31, 2015 | -0.108M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-57.14M
Minimum
Sep 2019
43.20M
Maximum
Mar 2020
3.319M
Average
2.767M
Median
Cash from Investing (Quarterly) Benchmarks
| PAVmed Inc | -0.042M |
| Moderna Inc | 118.00M |
| Altimmune Inc | -39.52M |
| iBio Inc | 1.00M |
| Lixte Biotechnology Holdings Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -31.10M |
| Cash from Financing (Quarterly) | -0.265M |
| Free Cash Flow | -103.90M |
| Free Cash Flow Per Share (Quarterly) | -0.7978 |
| Free Cash Flow Yield | -59.17% |